The American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine have jointly released a landmark publication that redefines heart health for girls and women. The three manuscripts, published in Circulation, represent the first coordinated, multi-society framework to prevent, detect, and manage cardiovascular disease across the female lifespan. The effort is significant because cardiovascular disease remains the leading cause of death in women, claiming more than 400,000 lives in the U.S. annually, yet only 41% of women recognize it as their greatest health threat.
The new approach introduces four distinct Female Life Stages based on hormonal changes unique to women: perimenarche (ages 8-15), ovarian cycling (ages 15-44), perimenopause (ages 45-51), and postmenopause (51 and older). Pregnancy is recognized as a biological stress test that can occur at any stage and may unmask previously unrecognized cardiovascular risks. This framework is detailed in the A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease presidential advisory, which establishes the life course construct.
Why does this matter? Progress in preventing cardiovascular deaths among women has stalled over the past two decades. A 2026 American Heart Association scientific statement projected that if trends continue, high blood pressure among U.S. women will rise from 49% in 2020 to 59% by 2050. Concurrently, maternal mortality has increased, with cardiovascular conditions accounting for more than one-third of pregnancy-related deaths. The new guidance aims to reverse these trends by equipping clinicians with shared tools to identify risk earlier.
The publications also highlight female-specific risk markers, such as menstrual cycle patterns as a vital sign and Perimenopause as a cardiovascular inflection point. The 2026 American Heart Association/American College of Cardiology cholesterol guideline now incorporates pregnancy-related factors into risk assessment. For clinicians, the American Heart Association PREVENT equations enable 10- and 30-year sex-specific risk estimation, supporting earlier prevention.
To translate evidence into practice, the societies call for a national network of Comprehensive Centers of Excellence for Women's Cardiovascular Care, built on four pillars: interdisciplinary clinical care, professional education, research, and community engagement. This infrastructure is mapped in the Comprehensive Centers of Excellence for Women's Cardiovascular Care science advisory. The clinical guidance is provided in the Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease scientific statement.
For the public, the American Heart Association offers resources such as A Woman’s Heart Through Every Stage of Life - A guide to protecting your heart from your first period through menopause and beyond and My Heart & Health Checklist - Questions to think about before your next visit. Additional details are available in the release link and the Spanish news release.
